| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |